HIPK3 and cancer: The depletion of circ-HIPK3 reduces cell proliferation, migration, invasion, and EMT of gemcitabine-resistant cells [126], implying that the circ-HIPK3/miR-330-5p/EMT axis may regulate the effect of other cancer therapies.